Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
CLSA upgrades NHPC to ‘High conviction outperform’ amid PTC stake speculation 
Business

CLSA upgrades NHPC to ‘High conviction outperform’ amid PTC stake speculation 

NHPC shares gained 1.35 per cent to ₹80.88 on the NSE today as brokerage firm CLSA upgraded the hydropower company to ‘High Conviction Outperform’ while

Markets end lower on US trade policy concerns; broader markets outperform
Business

Markets end lower on US trade policy concerns; broader markets outperform

Stock markets closed marginally lower for the third consecutive session on Tuesday, with the benchmark Sensex falling 203.22 points or 0.27 per cent to 75,735.96,

Macquarie initiates outperform rating on 4 Indian pharma stocks, sees 19-35% upside. Here’s why
Stock Market

Macquarie initiates outperform rating on 4 Indian pharma stocks, sees 19-35% upside. Here’s why

Indian pharma stocks: Macquarie Equity Research has initiated outperform ratings for Divi’s Labs, Suven Pharma, Bluejet Healthcare, and Syngene. Among the 11 companies covered in

Broker’s call: Samvardhana Motherson (Outperform)
Business

Broker’s call: Samvardhana Motherson (Outperform)

Target: ₹160 CMP:₹124.95 Samvardhana Motherson International’s (SAMIL) international organic business could remain under pressure in the near term. However, the ramp-up of its acquired businesses

Stock check: Axis Bank, down 7% YTD, to outperform Nifty 50 index in 2025? Here’s what technical data reveals
Stock Market

Stock check: Axis Bank, down 7% YTD, to outperform Nifty 50 index in 2025? Here’s what technical data reveals

Axis Bank stock check: The banking stock, in the last 7 months has declined from the highs of 1340 levels as observed on July 12,

Apollo Hospitals (Outperform) – The Hindu BusinessLine
Business

Apollo Hospitals (Outperform) – The Hindu BusinessLine

Target: ₹9,036 CMP: ₹6,374.90 Apollo Hospitals Enterprise (APHS) Q3-FY25 EBITDA marginally missed BNPP/Bloomberg estimates by 2/3 per cent, owing to moderately lower- than-expected growth in